SCHEMBL23730707

SCHEMBL23730707

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)nc(-c6cccc7c6oc6ccccc67)n5)c5sc6ccccc6c45)cc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.39
MAPT P10636 7/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 1/20 0.35
LIMK1 P53667 1/20 0.35
TSHR P16473 3/20 0.34
LMNA P02545 3/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
PIK3CD O00329 2/20 0.33
PIK3CB P42338 2/20 0.33
PRKDC P78527 2/20 0.33
CDC14B O60729 1/20 0.33
CDC14A Q9UNH5 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26228694 0.93 ALOX5 (0.37) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL24929010 0.92 ALOX5 (0.40) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL24929458 0.92 ALOX5 (0.40) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL24929013 0.92 ALOX5 (0.39) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL24929501 0.91 ALOX5 (0.38) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL26214558 0.91 LIMK1 (0.38) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL22311265 0.91 ALOX5 (0.36) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL26214452 0.91 PRKDC (0.39) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL26762620 0.91 LIMK1 (0.38) ALOX5MAPTALDH1A1KDM4EPOLB
SCHEMBL26238792 0.91 PRKDC (0.39) ALOX5MAPTALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same CRY1, CYP1B1, CYBA ALOX5 328/4885MAPT 2924/4885ALDH1A1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.